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Abstract 
Purpose: To evaluate the receptor-mediated neuroprotective effect of insulin-like growth factor-II (IGF-
II) on 1-methyl-4-phenyl pyridinium (MPP)-induced oxidative damage in adult cortical neuronal cultures.  
Methods:  Adult rats were randomly divided into 5 groups. Cortical neurons were prepared from rats. 
The cells were exposed to 10 μM of MPP (group 1, G1);  MPP + 100 ng/mL of IGF-II (group 2, G2); 
MPP + IGF in the presence of 20 ng/μL IGF-I analogue (group 3; G3); 5 ng/μL anti-IGF-IIR (group 4; 
G4); or MPP + IGF II + IGF inhibitor (group 5; G5). The level of reactive oxygen species (ROS), levels of 
oxidative stress markers, antioxidant enzymes, mitochondrial functional markers were analyzed in the 
MPP-treated neuronal cells (with or without treatment with IGF-II).  
Results: The results demonstrate that IGF-II treatment protects MPP-induced toxicity by decreasing 
ROS production (58.33 %; p ˂ 0.001), AChE levels (50 %), and maintaining the innate antioxidants to 
near normal levels. The study on oxidative functional markers showed that IGF-II significantly 
decreased the MPP-induced elevated levels and mitochondrial markers (TBARS, 40 %, LOOH-39.28 
%) to near normal levels. Further analysis using inhibitors of IGF-IR (IGF-I analogue) and IGF-IIR (anti-
IGF-IIR) showed that involvement of IGF-IIR might have greatly contributed to the neuroprotective effect 
of IGF-II.  
Conclusion: IGF-II receptors play a significant role in the neuroprotective mechanism of IGF-II by 
acting as an antioxidant, thereby reducing the neuro-degeneration induced by oxidative insults. This 
indicates that IGF-II receptors are a potential target for the treatment of diseases related to imbalance in 
redox homeostasis.  
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MPP is a highly toxic molecule which acts by 
interfering with oxidative phosphorylation in 
mitochondria, causing depletion of ATP and cell 
death [1]. It also inhibits the synthesis of 
catecholamines, reduces levels of dopamine and 
cardiac norepinephrine, and inactivates tyrosine 
hydroxylase. Recently, the use of neurotoxin 1-
methyl-4-phenylpyridinium (MPP), has enabled 
scientists to gain an insight into 
neurodegenerative pathogenesis experimentally. 
MPP has been reported to be a selective and 
potent inhibitor of complex I of the mitochondrial 
electron transport chain, leading to Parkinsonian 
symptoms in animal models [1,2]. 
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Insulin-like growth factors are naturally occurring 
peptides with known pleiotropic effects as growth 
factors(3) The majority of its actions are 
mediated primarily by insulin receptors, IGF-I 
receptors (IGF-IRs) and, IGF-II/mannose-6-
phosphate receptors (IGF-IIRs) [3]. Studies 
revealed that several IGF-binding proteins 
(IGFBPs) might enhance or abrogate the effects 
of IGF [4-6]. IGF-II, a 67 amino acid peptide   is 
synthesized highly during embryonic 
development. However, in adults, there is a 
decrease in its synthesis, although IGF-II 
remains the most abundant insulin-like peptide in 
the adult brain, primarily expressed in the choroid 
plexus, the leptomeninges and the hypothalamus 
[7]. In vitro studies have shown the 
neuroprotective effects of IGFs (I and II) as 
antioxidants via the regulation of intracellular 
calcium levels and the restoration of 
mitochondrial membrane potential (MMP) [8,9].  
Administration of low doses of IGF-II to 2-year 
old rats induced neuroprotective effects and 
decreased the levels of oxidative stress markers 
in the hippocampus and the cortex. These effects 
were attributed to IGF-II, as IGF-I plasma levels 
remained unchanged in these experimental 
animals [10]. 
 
Keeping in view the role of IGF-II receptors in 
neuroprotection, the present study was designed 
to elucidate the neuroprotective effect of IGF-II 
against the MPP-induced neurotoxicity using in-
vitro culture of adult cortical neuronal cells 




Preparation of cortical neuronal cultures 
 
The animals used were maintained in 
accordance with the Chinese legislation 
guidelines and according to the Helsinki 
Humanity Research Declaration during the 
experiments and the euthanasia of the animals. 
All the protocols were approved by the Ethical 
Committee of Department of Neurology, Yantai 
Economic and Technology Development Area 
Hospital, Yantai 264006, China (approval ref no. 
YETDAHY/2014/01072-A-2014).  
 
The cortical neurons were prepared from adult 
rats according to the method of Brewer [11]. The 
animals were decapitated and the cortex was 
subdivided into minute sections and then 
incubated in Hibernate ™-A/B27™ (Life 
Technologies, China) and papain for 30 min at 
30 °C in a gentle-shaking water bath. The cells 
obtained from triturating of sections were 
suspended in OptiPrep gradient medium (Sigma 
Aldrich) and centrifuged at 800 ×g for 15 min. 
The fractions containing neurons were collected, 
suspended in Hibernate ™-A/B27 and 
centrifuged twice at 200 ×g for 2 min at 20 oC. 
The pellets were then resuspended in growth 
culture medium. For cell culture, 6- and 24-well 
plates were pre-coated with 100 μg/mL of poly-
D-lysine.  
 
For immunohistochemical studies, glass 
coverslips (12 mm diameter) were pretreated 
with polyethylenimine (1/500 v/v in ddH2O) 
followed by 2.5 % FBS. Approximately 5 x 103 
(6-well plates) or 1.25 x 104 (24-well plates) cells 
were seeded. The neurons were then incubated 
at 37 °C in 5 % CO2, and after 1 h, the wells 
were rinsed twice with Neurobasal™-A and filled 
with growth culture medium. The media were 
replaced with fresh media (half of the initial 
volume) every 4 days. Cell growth was monitored 
for 12 days before commencing the experiments. 
Table 1 shows the treatment of cortical neuronal 
cells and determination of experimental groups 
(G1 to G5).  
 
Determination of cell death and ROS 
measurement 
 
As IGF-II is known for the activation of IGF 
receptors IGF-IR and IGF-IIR, we performed the 
receptor-inhibition study to reveal the 
involvement of IGF receptors during the IGF-II 
treatment against MPP. The neuronal cells were 
seeded in a 96-well tissue culture plate, at a 
density of approximately 1.25 x 104 cells/well, for 
24 h the cells that were in serum-free media for 
24 h were subjected to measurement of ROS 
production and cell death. Intracellular ROS 
generations were measured using a well-
characterized probe, DCFH-DA. DCFH-DA is 
hydrolyzed by esterases to dichlorofluorescin 
(DCFH), which is trapped within the cell. This 
non fluorescent molecule is then oxidized to 
fluorescent dichlorofluorescin (DCF) by the 
action of cellular oxidants. The cells of 
experimental groups were also subjected to 
DCFH staining and the fluorescence was 
determined at 485 nm excitation and 520 nm 
emission, using a micro plate reader (FLUO star, 
BMG Lab technologies, NC, USA).  
 
Evaluation of acetyl cholinesterase activity 
 
Acetyl cholinesterase (AChE) activity was 
determined in cell extracts of experimental 
groups using acetylcholine iodide as a substrate 
according to the method of Ellman [12]. In this 
method AChE in samples hydrolyzes acetyl 
thiocholine iodide into thiocholine and butyric 
acid. The thiocholine reacts with 5, 5′-dithiobis-2-
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nitrobenzoic acid to form 5-thio-2-nitrobenzoic 
acid. The yellow colour developed is measured 
spectrophotometrically at 412 nm (PIOWAY, 
Focus Technology Co., Ltd.).   
 
Evaluation of oxidative stress markers  
 
The concentration of thiobarbituric acid reactive 
substances (TBARS) were estimated in cell 
extracts of experimental groups by the method of 
Niehaus and Samuelsson [13] using 1,1′,3,3′-
tetramethoxypropane as the standard. Lipid 
hydroperoxides (LOOH) in cell extracts of 
experimental groups were assayed as described 
by Jiang [14]. 
 
Measurement of mitochondrial function 
markers 
 
As mitochondrial function markers, we chose 
mitochondrial membrane potential (MMP) and 
cytochrome-c oxidase activity. MMP was 
evaluated using the JC-1 Mitochondrial 
Membrane Potential Assay Kit (Cayman 
Chemical Company, Ann Arbor, Michigan, USA). 
Cytochrome-c oxidase activity in cell 
homogenates was assessed using a 
cytochrome-c oxidase assay kit (Sigma Aldrich, 
China) adapted to a Cobas Mira Autoanalyser 
[15]. One unit was defined as the oxidation of 1.0 
μmol of ferrocytochrome c per minute at pH 7.0 
and 37 °C. 
 
Evaluation of antioxidant levels 
 
The cells were washed with ice-cold phosphate 
buffered saline (PBS) and were lysed with RIPA 
buffer (Cell Signaling Technology). The lysates 
were centrifuged, and the protein content of the 
supernatant was determined by the Bradford 
method [16]. About 10–20 µg of protein was 
loaded and separated by 10 % SDS–PAGE and 
blotted onto a polyvinylidene fluoride membrane. 
Then, the membranes were blocked with 5 % 
non-fat dry milk powder solution for 1 h at room 
temperature before an overnight incubation with 
primary antibodies (catalase (CAT), glutathione 
peroxidase (GPx) and superoxide dismutase 
(SOD) (purchased from BD Biosciences) at 4 oC. 
After rinsing the membranes, they were 
incubated with secondary antibody for 1 h at 
room temperature and finally developed through 
Alpha InfoTech Fluor Chem. HD2 Imaging 
System (Alpha Innotech). All antibodies, with the 
exception of -tubulin, were used at a 1:250 
dilution. The antibodies of -tubulin were used at 
a 1:1000 dilution.   
Statistical analysis 
 
The data are expressed as mean ± standard 
deviation (SD) for six animals in each group. 
Differences between groups were assessed by a 
one-way analysis of variance (ANOVA) using 
SPSS software package for Windows (Version 
11.5; SPSS Inc., Chicago, IL, USA). Post hoc 
testing was performed for inter-group 
comparisons using the least significance 




IGF-II prevents MPP- induced ROS production 
and cell death 
 
The cells exposed to 10 μM of MPP (G1) showed 
a significant increase in percentage of ROS 
production and cell death. However, cells 
exposed to MPP and treated with 100 ng/mL of 
IGF-II (G2) had significantly reduced ROS 
production (58.33 %, p < 0.001) and cell death 
(76 %, p < 0.04) when compared to G1 (Figure 
1). Protective effect was observed in cells 
exposed to MPP and treated with IGF in the 
presence of 20 ng/μL IGF-I analogue (G3) or 5 
ng/μL anti-IGF-IIR (G4). However, an increase in 
ROS (50 %) and cell death (77.14 %) was 
observed in the cells exposed to MPP in the 
presence of IGF-II with both inhibitors of IGF 
receptors (G5) Vs G2. 
 
Activities of AChE and oxidative stress 
markers 
 
The activity of AChE in cortical neuronal cells 
exposed to MPP was found significantly (61.11 
%, p < 0.05) decreased when compared to 
control (Figure 2a). However, this MPP 
mediated-toxicity was controlled by the 
administration of IGF-II (50 %, G2 Vs G1). 
Consistently, IGF-II treatment had significantly 
decreased the levels of MPP-induced oxidative 
markers (TBARS-40 %; LOOH- 39.28 %: G2 Vs 
G1) (Figure 2b). The inhibition study also showed 
decrease in the oxidative marker suggesting the 
contributions of IGF receptors in IGF-II treatment 
in neural cells against MPP exposure (Figure 
IIb). 
 
IGF-II improved the activity of mitochondrial 
markers  
 
The cells exposed to MPP showed a significant 
decrease in MMP and cytochrome-C oxidase 
activity (Figure 3). However, IGF-II treatment 
restored   these   activities   to  near  normal.  No  
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Figure 1: Graphical representation showing percentage of ROS production and cell death in adult cortical 
neuronal cells in the experimental groups (G) as mentioned in Table I. *- Indicate the significant (p < 0.05) 
difference from IGF-II treated group (G2). 
                              
        Table 1: Cell culture treatment and experimental grouping 
 
Cell treatment Experimental Groups (G) Cont. G1 G2 G3 G4 G5 
1-methyl-4-phenyl pyridinium (MPP; 10 μM) - + + + + + 
IGF-II (100 ng/mL) - - + + + + 
IGF-I analogue (20 ng/μL) - - - + - + 




Figure 2: (a) Activity level of acetylcholine esterase measured in the experimental groups (G) as mentioned 
Table I. # Indicate the significant (p < 0.001) difference from IGF-II treated group (G2); *indicate the significant (p 
< 0.05) difference from IGF-I analogue (IGF-IR inhibitor) treated group (G3). b. Represent the level of oxidative 
stress or lipid peroxidation markers TBARS and LOOH in the experimental groups. * -Indicate the significant (p < 
0.001) difference from IGF-II treated group (G2) 
 
changes were detected upon incubation in MPP, 
IGF-II and either inhibitor of IGF receptors, 
whereas co-incubation with both inhibitors 
restored the MMP/ cytochrome-c oxidase 
activities to that of the MPP-treated cells (Fig 3). 
 
IGF-II improved the antioxidant level 
 
MPP-exposed cells showed significantly (p < 
0.05) decreased protein levels of CAT (60.86 %), 
SOD (61.11 %) and Gpx (70 %), which were 
restored by treatment with IGF-II 55, 56.25 and 
70 %, respectively (Figure 4a-c). While as IGF 
inhibition also showed the protective effect 
individually, there was, however, little or no 
protective effect when administered with both 
inhibitors (IGF-1 analogue and anti-IGF-IIR) 




IGF-II remains the most abundant insulin-like 
peptide in the adult brain, primarily expressed in 
the  choroid plexus,  the  leptomeninges and the  
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Figure 3: Graphical representation showing the activity of mitochondrial functional markers MMP (a) and 
cytochrome-c oxidase (b) in the experimental groups. # Indicate significant (p <0.001) difference from control 
group; $ indicate significant (p < 0.001) difference from MPP-exposed group (G1); *indicate significant (p < 0.05) 





Figure 4: Western blot data for antioxidant enzymes: 
(a) catalase, (b) superoxide dismutase and (c) 
glutathione peroxidase in the experimental groups. 
Band intensities were quantified, calibrated/normalized 
with the bands of -tubulin and represented in the bar 
graph 
hypothalamus [10]. IGF-II is capable of activating 
the IGF receptors (IGF-IR and IGF-IIR), in 
which,IGF-IIR is the most abundant insulin-like 
receptor in the adult brain. The physiological 
actions of IGF-II in adults are not well defined, 
although some studies have demonstrated an 
association of these peptides with cognitive 
processes, such as memory [17], and neuro-
protection against neurodegenerative disorders.  
The present study was focused towards the 
protective effects of IGF-II and the supporting 
factors involved in the IGF-II mediated neuro-
protection. The cultures of cortical neurons from 
adult rats were treated with high concentration of 
MPP for the quick induction of oxidative stress or 
neurotoxicity. The low concentration of IGF-II 
was chosen based on the results of previous 
experiments that demonstrated the capacity of 
IGF-II to induce neuroprotection by reducing 
oxidative stress in the cortex and the 
hippocampus of aged rats [18].  
 
Excessive amounts of ROS and mitochondrial 
dysfunction are among the major mechanisms 
that trigger neurodegeneration [19]. In the 
present study, the percentage of ROS production 
and the cell death was significantly increased in 
MPP-exposed cells, and it was found that IGF-
IIR plays major role than that of IGF-IR. Similar 
effects of IGF-II on these oxidative markers have 
also been reported in the aged brain (4). To 
reveal the supportive factors for IGF-II mediated 
protection (7), we incorporated the study on IGF 
receptors specific inhibitors (IGF-1 analogue and 
anti-IGF-IIR). The results showed the protective 
effect of IGF-II against MPP in individual inhibitor 
treatment but no protective effect was found in 
simultaneous treatment of both inhibitors. These 
results clearly predict the involvement of IGF 
receptors in IGF-II mediated neuroprotection, 
which is consistent with the previous reports [20].  
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Numerous studies have suggested that the free 
radical production could at least associate with 
the decreased activity of brain AChE [21]. The 
brain AChE activity is an important regulator of 
the behavioral processes; in the present study, 
the decreased level of AChE in neuronal cells 
might be one of the indicators for MPP induced 
toxicity, whereas IGF-II treatment restored the 
activity of AChE. In addition, we have evaluated 
the effect of IGF-II on MPP-induced oxidative 
stress markers (TBARS and LOOH), which are 
related to damage to lipid membrane. The 
elevated level of TBARS and LOOH was 
decreased to near control levels. To assess 
mitochondrial function, oxidative phosphorylation 
was evaluated by measuring the MMP [22] and 
mitochondrial cytochrome-c oxidase activity, 
which is the rate-limiting step of the mitochondrial 
respiratory chain [23]. JC-1 fluorescence was 
measured which reflects the average MMP of all 
mitochondria inside the cells. Both MMP and 
cytochrome-c oxidase activity was restored upon 
IGF-II treatment against MPP exposure. 
Mitochondrial membrane potential (MMP) and 
cytochrome-c oxidase activity were measured as 
the markers of respiratory chain to determine the 
mitochondrial function. Our inhibitor study on 
MMP and cytochrome-c oxidase further 
supported the involvement of IGF receptors in 
the protective effect of IGF-II. In addition, IGF-II 
protected the MPP-induced decrease in 
antioxidant protein levels of CAT, SOD and Gpx 
in neuronal cells, which is supported by the 
involvement of IGF receptors. Our study revealed 
that IGF-II functions under the influence of IGF 
receptors and in particular view our results 
suggest that IGF-IIR involvement is more 




IGF-II exhibits a neuroprotective effect on MPP-
exposed cortical neuronal cells. The results 
reveal that the protective effect of IGF is 
supported by the involvement of IGF-II activated 
IGF receptors. Thus, IGF-II may be a good 
therapeutic target for various neurodegenerative 
disorders such as Parkinson’s disease. However, 
further elucidation of the exact molecular 




1. Eberhardt O, Schulz JB. Apoptotic mechanisms and 
antiapoptotic therapy in the MPTP model of 
Parkinson's disease. Toxicol Lett 2003; 139: 135-151. 
2. Przedborski S, Jackson-Lewis V. Mechanisms of MPTP 
toxicity. Mov. Disord. 1998, 13 (Suppl 1), 35-38. 
3. Kusky J O, Ye P. Neurodevelopmental effects of insulin-
like growth factor signaling, Front. Neuroendocrinol. 
2012; 33: 230–251. 
4. Holly JM, Perks CM. Insulin-like growth factor physiology: 
what we have learned from human studies, 
Endocrinol. Metab. Clin. North Am. 2012; 41: 249–
263. 
5. LeRoith D, Kavsan VM, Koval AP, Roberts Jr CT. 
Phylogeny of the insulin-like growth factors (IGFs) 
and receptors: a molecular approach, Mol. Reprod. 
Dev. 1993; 35: 332–336. 
6. Marquardt H, Todaro GJ, Henderson LE, Oroszlan S. 
Purification and primary structure of a polypeptide 
with multiplication-stimulating activity from rat liver 
cell cultures. Homology with human insulin-like 
growth factor II, J. Biol. Chem. 1981; 256:  6859–
6865. 
7. Agis-Balboa RC, Fischer A. Generating new neurons to 
circumvent your fears: the role of IGF signaling, Cell. 
Mol. Life Sci. 2014; 71: 21–42. 
8. Mattson MP, Cheng B, Smith-Swintosky VL. Mechanisms 
of neurotrophic factor protection against calcium- and 
free radical-mediated excitotoxic injury: implications 
for treating neurodegenerative disorders, Exp. 
Neurol. 1993; 124: 89–95. 
9. Mattson MP, Zhang Y, Bose S. Growth factors prevent 
mitochondrial dysfunction, loss of calcium 
homeostasis, and cell injury, but not ATP depletion in 
hippocampal neurons deprived of glucose, Exp. 
Neurol. 1993;121: 1–13. 
10. Castilla-Cortazar I, Garcia-Fernandez M, Delgado G, 
Puche JE, Sierra I, Barhoum R, Gonzalez-Baron S. 
Hepatoprotection and neuroprotection induced by low 
doses of IGF-II in aging rats, J. Transl. Med. 2011; 9: 
103.58-76 
11. Brewer GJ. Isolation and culture of adult rat hippocampal 
neurons, J. Neurosci. Methods 1997; 71: 143–155. 
12. Ellman GL, Courtney KD, Andres VJ, Featherstone RMA. 
A new and rapid colorimetric determination of acetyl 
cholinesterase activity. Biochem Pharmacol 1961; 7: 
88-95. 
13. Niehaus WG, Samuelsson D. Formation of 
malondialdehyde from phospholipid arachidonate 
during microsomal lipid peroxidation. Eur J Biochem 
1968; 6: 126-130. 
14. Jiang ZY, Hunt JV, Wolff SP. Ferrous ion oxidation in the 
presence of xylenol orange for detection of lipid 
hydroperoxides in low density lipoproteins. Anal 
Biochem 1992; 202: 384-387. 
15. García-Fernández M, Castilla-Ortega E, Pedraza C., 
Blanco E, Hurtado-Guerrero ., Barbancho MA, Chun 
J, Rodríguez-de-Fonseca F, Estivill-Torrús G, L. 
Núñez JS. Chronic immobilization in the malpar1 
knockout mice increases oxidative stress in the 
hippocampus, Int. J. Neurosci. 2012; 122: 583–589. 
Dong et al 
Trop J Pharm Res, July 2015; 14(7): 1197  
 
16. Bradford MM. A rapid and sensitive method for the 
quantitation of microgram quantities of protein 
utilizing the principle of protein-dye binding. Anal 
Biochem 1976; 72: 248–254. 
17. Chen DY, Stern SA, Garcia-Osta AB, Saunier-Rebori, 
Pollonini, G, Bambah- Mukku D, Blitzer RD, Alberini 
CM. A critical role for IGF-II in memory consolidation 
and enhancement, Nature 2011; 469: 491–497. 
18. Garcia-Fernandez M, Sierra I, Puche JE, Guerra L, 
Castilla-Cortazar I. Liver mitochondrial dysfunction is 
reverted by insulin-like growth factor II (IGF-II) in 
aging rats, J. Transl. Med. 2011; 9: 123:34-57. 
19. Wang X, Michaelis EK., Selective neuronal vulnerability 
to oxidative stress in the brain, Front. Aging Neurosci. 
2010; 2: 12. 
20. Hawkes C, Jhamandas JH., Harris KH., Fu W, 
MacDonald RG, Kar S., Single transmembrane 
domain insulin-like growth factor-II/mannose-6-
phosphate receptor regulates central cholinergic 
function by activating a G-protein-sensitive, protein 
kinase C-dependent pathway, J. Neurosci.2006; 26: 
585–596. 
21. Tsakiris S, Angelogianni P, Schulpis KH, Starridis JC. 
Protective effect of L-phenylalanine on rat brain 
acetyl cholinesterase inhibition induced by free 
radicals. Clin Biochem 2000; 33: 103-106. 
22. Iijima T., Mitochondrial membrane potential and ischemic 
neuronal death, Neurosci. Res. 2006; 55: 234–243. 
23. Arnold S. Cytochrome C oxidase and its role in 
neurodegeneration and neuroprotection, Adv. Exp. 
Med. Biol. 2012; 748: 305–339. 
 
